Publications

You can use the filters to show only results that match your interests

Filter publications
393 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  2. Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients

  3. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  4. Medical devices: software applications (apps)

  5. E-learning modules: medicines

    • MHRA
    • Guidance
  6. Medicines: notes for applicants and holders of a wholesale dealer licence or broker registration

  7. MHRA Privacy Notice

    • MHRA
    • Transparency data
  8. Medicines: new manufacturing and wholesale dealer licences

  9. Register of brokers authorised to deal in human medicines

  10. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  11. Human and veterinary medicines: register of licensed wholesale distribution sites

  12. Human and veterinary medicines: register of licensed manufacturing sites

  13. Marketing authorisations granted in May 2018

  14. Parallel import licenses granted in May 2018

  15. Review Panel Annual Report 2017

    • MHRA
    • Corporate report
  16. Annual reports of the ABRHP and the HMAC

    • MHRA
    • Corporate report
  17. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  18. Early access to medicines scheme (EAMS) scientific opinion: Volanesorsen as a treatment of adult patients with familial chylomicronaemia syndrome

  19. Early access to medicines scheme (EAMS) scientific opinion: Nivolumab to treat advanced or recurrent gastric or gastroesophageal junction cancer after two or more systemic therapies

  20. Government response to report on Brexit and medicines, medical devices and substances of human origin

    • DHSC, IPO, MHRA, OLS and DExEU
    • Policy paper
  21. Human Medicines Regulations 2012 Advisory Bodies annual report 2017

    • MHRA
    • Corporate report
  22. Common issues identified during clinical trial applications

    • MHRA
    • Guidance
  23. Medicines and Healthcare products Regulatory Agency Business Plan 2018 to 19

    • MHRA
    • Corporate report
  24. Marketing authorisations granted in April 2018

  25. Parallel import licenses granted in April 2018

  26. Good clinical practice inspection metrics

  27. Good clinical practice inspection metrics

  28. MHRA: policy for handling conflicts of interest

    • MHRA
    • Corporate report
  29. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  30. Advertising investigations: March 2018

  31. Advertising investigations: April 2018

  32. MHRA Corporate Plan 2018 to 2023

    • MHRA
    • Corporate report
  33. Advertising investigations: February 2018

  34. Marketing authorisations granted in March 2018

  35. Parallel import licenses granted in March 2018

  36. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  37. Advertising investigations: January 2018

  38. Marketing authorisations granted in February 2018

  39. Parallel import licenses granted in February 2018

  40. Medicines and Healthcare products Regulatory Agency board member expenses from July to September 2016

    • MHRA
    • Transparency data